Search by Drug Name or NDC
NDC 60687-0673-21 Nateglinide 60 mg/1 Details
Nateglinide 60 mg/1
Nateglinide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is NATEGLINIDE.
MedlinePlus Drug Summary
Nateglinide is used alone or in combination with other medications to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) in people whose diabetes cannot be controlled by diet and exercise alone. Nateglinide belongs to a class of drugs called meglitinides. Nateglinide helps your body regulate the amount of glucose (sugar) in your blood. It decreases the amount of glucose by stimulating the pancreas to release insulin. Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Related Packages: 60687-0673-21Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Nateglinide
Product Information
NDC | 60687-0673 |
---|---|
Product ID | 60687-673_f5ca1d48-7f30-b826-e053-2a95a90a10dc |
Associated GPIs | |
GCN Sequence Number | 047333 |
GCN Sequence Number Description | nateglinide TABLET 60 MG ORAL |
HIC3 | C4K |
HIC3 Description | ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE |
GCN | 12277 |
HICL Sequence Number | 021859 |
HICL Sequence Number Description | NATEGLINIDE |
Brand/Generic | Generic |
Proprietary Name | Nateglinide |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | nateglinide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 60 |
Active Ingredient Units | mg/1 |
Substance Name | NATEGLINIDE |
Labeler Name | American Health Packaging |
Pharmaceutical Class | Glinide [EPC], Potassium Channel Antagonists [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA077463 |
Listing Certified Through | 2024-12-31 |
Package
NDC 60687-0673-21 (60687067321)
NDC Package Code | 60687-673-21 |
---|---|
Billing NDC | 60687067321 |
Package | 30 BLISTER PACK in 1 CARTON (60687-673-21) / 1 TABLET in 1 BLISTER PACK (60687-673-11) |
Marketing Start Date | 2023-01-12 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.18426 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | NATEGLINIDE 60 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |